Cerebral Embolic Protection in Patients Undergoing Left Atrial Appendage Closure

Julia Seeger1,2, Philipp Seppelt3, Mario Iturbe-Orbe1

  • 1Department of Cardiology and Intensive Care, Medical Campus Lake Constance, 88048 Friedrichshafen, Germany.

Insights

Cerebral embolic protection during left atrial appendage (LAA) closure with the WATCHMAN FLX device captured minimal debris, primarily thrombi. This procedure showed no periprocedural strokes, indicating a safe and effective method for LAA occlusion.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Cerebral ischemic lesions are reported in approximately one-third of patients post-left atrial appendage (LAA) closure.
  • Stroke events often occur during the periprocedural period of LAA closure.

Purpose of the Study:

  • To evaluate the characteristics of embolized debris captured by the SENTINEL cerebral embolic protection system during LAA closure.
  • To assess the safety and efficacy of LAA occlusion using the WATCHMAN FLX device.

Main Methods:

  • Sixty filters from 30 patients undergoing LAA closure with the WATCHMAN FLX device were analyzed.
  • Histopathology and histomorphometry were used to examine captured debris.
  • Clinical outcomes, including stroke within 72 hours, were monitored.

Main Results:

  • The majority of filters contained no captured material.
  • Predominant debris consisted of acute or organized thrombi (33.3% of patients).
  • Heart tissue particles were found in 20% of patients; foreign material in 3.3%.
  • No disabling or non-disabling strokes occurred.
  • The number of captured particles was significantly lower compared to other procedures like TAVR.

Conclusions:

  • Left atrial appendage occlusion with the WATCHMAN FLX device is associated with a very low embolic load.
  • The SENTINEL dual-filter embolic protection system effectively captured debris.
  • No periprocedural strokes were observed, suggesting a safe intervention.